• Home
  • PR

PR

News

게시물 상세
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
Date : 2022-03-22     View : 438

 

OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference

 

 

Suwon, Republic of Korea, February 07, 2022 (GLOBE NEWSWIRE) – OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will present at the SMi 13th Annual RNA Therapeutics Conference taking place virtually February 9-10, 2022.

 

Dong Ki Lee, Ph.D., Founder and Chief Executive Officer of OliX, will deliver an opening address focused on the company’s proprietary asymmetric siRNA technology and pipeline programs, including OLX104C for hair loss, OLX301A for wet/dry age-related macular degeneration (AMD), OLX702A for non-alcoholic steatohepatitis (NASH), and OLX703A for hepatitis B virus (HBV).

 

 

Details for the upcoming presentation are below:

 

SMi 13th Annual RNA Therapeutics Conference

 

 

###


Prev OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress
Next OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences